BioCardia, Inc.
Price Action
Technical Summary
DOWNTRENDBioCardia, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 20), showing significant lag compared to the market leaders. Earnings contraction of 386% provides fundamental context to the price action. Investors should exercise caution due to high volatility (76% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.16 | -5.91% | BELOW |
| 50 SMA | $1.20 | -8.97% | BELOW |
| 100 SMA | $1.23 | -11.50% | BELOW |
| 150 SMA | $1.28 | -14.92% | BELOW |
| 200 SMA | $1.42 | -23.44% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BCDA in an uptrend right now?
BCDA has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is BCDA overbought or oversold?
BCDA's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is BCDA outperforming the market?
BCDA has a Relative Strength (RS) Rating of 20 out of 99. BCDA is currently lagging the broader market.
Where is BCDA in its 52-week range?
BCDA is trading at $1.09, which is 37% of its 52-week high ($2.92) and 5% above its 52-week low ($1.00).
How volatile is BCDA?
BCDA has a Beta of 1.14 and 52-week volatility of 76%. It's more volatile than the S&P 500 - expect bigger swings.